TriSalus Life Sciences, Inc. Common Stock
TLSI •
Buy Open
Signal type
Buy
Status
Open
Open Price
$4.43
Stop Loss
$3.57
Performance
-0.68%
Days Open
5
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 10, 2026
Open Price $4.43
Stop Loss $3.57
Timespan Day
Company Profile
Name TriSalus Life Sciences, Inc. Common Stock
Ticker TLSI
Market Cap $206.97M
Sector SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Latest Close $4.40
List Date Aug 11, 2023
Description
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
Website Open Company Website